# Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis

> **NCT01029821** · NA · UNKNOWN · sponsor: **University of Tennessee** · enrollment: 100 (estimated)

## Conditions studied

- Deep Venous Thrombosis

## Interventions

- **DRUG:** Low-Molecular-Weight Heparin

## Key facts

- **NCT ID:** NCT01029821
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01029821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01029821, "Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01029821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*